Business
Press Release Jul 22 2024
Zydus Lifesciences Limited has informed the Exchange regarding a press release dated July 22, 2024, titled "Zydus receives approval from COFEPRIS of Mexico to market Bhava (Bevacizumab biosimilar) to treat various cancers".
About this update from Zydus Lifesciences Limited
[{"type":"text","content":" Zydus Lifesciences Limited has informed the Exchange regarding a press release dated July 22, 2024, titled \"Zydus receives approval from COFEPRIS of Mexico to market Bhava (Bevacizumab biosimilar) to treat various cancers\". View Attachment","length":378,"tagName":"div"}]